![]() |
市場調查報告書
商品編碼
1497639
單採設備市場:按產品、程序、技術和應用 - 全球預測 2024-2030Apheresis Equipment Market by Product (Apheresis Machine, Disposable Apheresis Kits), Procedure (Erythrocytapheresis, LDL-Apheresis, Leukapheresis), Technology, Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年單採設備市場規模為29億美元,預計2024年將達31.5億美元,2030年將達53.2億美元,複合年成長率為9.06%。
單採設備是醫療設備,單採是一種醫療程序,從患者或捐贈者身上取出全血,將其分離成單獨的成分,保留這些成分中的一種或多種,並將剩餘部分返回給患者或捐贈者。分離過程可以分離回收血漿(血液的液體部分)、血小板(幫助血液凝固的細胞)、紅血球和白血球等成分。癌症和自體免疫疾病等需要血液成分治療的疾病的發生率不斷增加,推動了對單採術的需求。單採設備的創新使程序更加高效和安全,也推動了市場的成長。人們對各種疾病的單採療法的可用性的認知不斷提高也推動了市場的擴張。然而,缺乏對血漿分離術治療益處的認知可能會阻礙市場成長。新設備核准的嚴格監管要求可能會延遲產品上市並增加市場開拓成本,對市場成長構成挑戰。此外,自動化和整合系統等單採技術的創新提供了佔領新細分市場的潛力。新興國家醫療保健投資的增加是市場擴張的重大機會。
主要市場統計 | |
---|---|
基準年[2023] | 29億美元 |
預測年份 [2024] | 31.5億美元 |
預測年份 [2030] | 53.2億美元 |
複合年成長率(%) | 9.06% |
區域洞察
由於發達的醫療基礎設施、較高的捐血意識以及需要血漿和其他血液成分進行治療的疾病的流行,美洲(尤其是美國和加拿大)對單採設備的需求很高。最近的投資旨在提高單採程序的效率和安全性,美洲地區的多項專利旨在最大限度地降低污染風險並改善自動化分離過程。歐洲國家對捐血和血液處理有嚴格的規定,並且注重醫療保健研發,單採血液的需求旺盛。中東和非洲地區的單採設備呈現多樣化的格局,一些國家迅速發展醫療基礎設施,為該地區的市場成長做出了貢獻。亞太地區對單採設備的需求正在顯著成長,特別是在中國、日本和印度。醫療保健成本不斷上升、人們對捐血重要性的認知不斷提高以及慢性病患病率不斷上升,推動了亞太地區單採設備的迅速採用。在日本,技術先進的設備是首選,而在中國和印度,由於人口眾多,成本效益和擴充性很重要。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在單採設備市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對單採設備市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在單採設備市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[193 Pages Report] The Apheresis Equipment Market size was estimated at USD 2.90 billion in 2023 and expected to reach USD 3.15 billion in 2024, at a CAGR 9.06% to reach USD 5.32 billion by 2030.
Apheresis equipment refers to medical devices used in apheresis, a medical procedure that involves removing whole blood from a patient or donor, separating it into individual components, and retaining one or more of these components while the rest are returned to the patient or donor. The separation process can isolate and collect components such as plasma (the liquid part of the blood), platelets (cells that help blood to clot), red blood cells, and white blood cells. Increased incidence of conditions that require blood component therapies, such as cancer and autoimmune diseases, drives demand for apheresis procedures. Technological innovations in apheresis equipment, making procedures more efficient and safe, also fuel market growth. Enhanced awareness regarding the availability of apheresis treatments for various conditions supports market expansion. However, a lack of awareness about the benefits of apheresis treatments may hinder market growth. Stringent regulatory requirements for approval of new devices may delay product launches and increase development costs, creating challenges for market growth. Moreover, innovation in apheresis technologies, such as automation and integrated systems, offers the potential for capturing new market segments. Increasing healthcare investments in emerging economies present significant opportunities for market expansion.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.90 billion |
Estimated Year [2024] | USD 3.15 billion |
Forecast Year [2030] | USD 5.32 billion |
CAGR (%) | 9.06% |
Regional Insights
In the Americas, with a particular focus on the United States and Canada, there is a high demand for apheresis equipment due to the developed healthcare infrastructure, high awareness levels about blood donation, and the prevalence of diseases requiring plasma and other blood components for treatment. Recent investments have been directed toward enhancing the efficiency and safety of apheresis procedures, with several patents filed in the Americas region, aiming to minimize contamination risks and improve automated separation processes. European countries exhibit robust demand for apheresis equipment, driven by strict regulations pertaining to blood donation and handling, as well as a strong focus on healthcare research and development. The Middle East and Africa region presents a varied landscape for apheresis equipment, with certain countries rapidly developing their healthcare infrastructure, contributing to the market growth in the region. The APAC region, particularly China, Japan, and India, is witnessing substantial growth in demand for apheresis equipment. The surge in adoption of apheresis equipment in the APAC region is propelled by increasing healthcare expenditure, rising awareness about the importance of blood donation, and a growing prevalence of chronic diseases. In Japan, the market is characterized by a preference for technologically advanced equipment, while in China and India, there's a focus on cost-effectiveness and scalability to meet the large population's needs.
Market Insights
The market dynamics represent an ever-changing landscape of the Apheresis Equipment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Apheresis Equipment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Apheresis Equipment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Enhancing Sickle Cell Treatment in England, A GBP 1.5 Million Investment in Advanced Apheresis Technology
In a significant development aimed at improving healthcare services for sickle cell disease patients in England, NHS England has announced a GBP 1.5 million (USD 1.8 million) investment to acquire 25 Spectra Optia Apheresis System devices. The automated red blood cell exchange offered by the Spectra Optia device aims to minimize these transfusions and also to manage pain more effectively and reduce the risk of crises. [Published On: 2024-02-14]
Revolutionizing Cell & Gene Therapy, A Transformative Partnership between Be The Match BioTherapies and Cryoport
Be The Match BioTherapies and Cryoport have embarked on a strategic alliance that greatly enhances the capabilities of IntegriCell, an integrated bioprocessing, cryopreservation, and distribution platform catering to the global cell therapy sector. This groundbreaking collaboration aims to streamline the entire bioprocessing and cryopreservation journey-spanning from the U.S. to Europe-by merging Be The Match BioTherapies' expertise in donor management and high-quality material collection with Cryoport's advanced cryopreservation, bioprocessing, and global logistics solutions. [Published On: 2023-10-09]
Sanguine Biosciences Opens Innovative Blood Donor Center for Enhanced Biomedical Research
Sanguine Biosciences has launched a cutting-edge blood donor center in Los Angeles, California, marking a significant milestone in precision medicine research and development. This facility is dedicated to the collection of concentrated white blood cell biospecimens, also known as leukopaks, from its extensive Patient Community network. This development underscores Sanguine's ambition to be at the forefront of providing valuable translational biospecimens to the biomedical research sector, leveraging its powerful patient engagement strategies and robust procurement capabilities. [Published On: 2023-09-13]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Apheresis Equipment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Apheresis Equipment Market, highlighting leading vendors and their innovative profiles. These include Aikang Diagnostics Co., Ltd., Asahi Kasei Kuraray Medical Co. Ltd., B. Braun Melsungen AG, Bioelettronica S.r.l., Braun & Co. Limited, Cerus Corporation, Charles River Laboratories International, Inc., Cytosorbents Corporation, Delcon S.r.l., Fresenius Kabi AG, Haemonetics Corporation, Isto Biologics, JMS North America Corporation, Kaneka Corporation, LMB Technologie GmbH, Maco Pharma SAS, Mallinckrodt Pharmaceuticals Ireland Limited, MEDICA S.P.A., Medicap Clinic GmbH, Micro Technologies, Miltenyi Biotec B.V. & Co. KG, Nikkiso Co., Ltd., SB-Kawasumi Laboratories, Inc., and Terumo BCT Inc..
Market Segmentation & Coverage